Sonic Healthcare – Buy Write 10% cash flow

Sonic Healthcare is under Algo Engine buy conditions and is a current holding within the ASX 100 model portfolio.

SHL has strengthened its US footprint with the purchase of Aurora Diagnostics for US$540m, (A$750m), mainly funded with up to a A$700m equity raise.

You're not a member!  Trial today!

The placement is priced at A$19.50/share, an 8.8% discount to the last
close price.

FY19 revenue $6.2bn, EBITDA $1.1bn, net profit $5.30mn, EPS $1.22, DPS$0.90 places Sonic on a forward yield of 4.5%

We recommend buying Sonic Healthcare and selling a covered call option to enhance the income.



Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2020 Investor Signals